Industries - Cancer Stem Cells Market Analysis by Mode of Action (Targeted Cancer Stem Cells, Stem Cell-based Cancer Therapy), by Cancer Type (Blood, Breast, Lungs, Colorectal, Brain, Bladder, Pancreas, Liver), and by Region – Forecast to 2026

Ablation Technology Market Analysis

Cancer Stem Cells Market Analysis by Mode of Action (Targeted Cancer Stem Cells, Stem Cell-based Cancer Therapy), by Cancer Type (Blood, Breast, Lungs, Colorectal, Brain, Bladder, Pancreas, Liver), and by Region – Forecast to 2026
April 2021

SKU: N/A Categories: ,
Clear
  • Description
  • Additional information
  • Enquire about

Description

Cancer Stem Cells Market Analysis by Mode of Action (Targeted Cancer Stem Cells, Stem Cell-based Cancer Therapy), by Cancer Type (Blood, Breast, Lungs, Colorectal, Brain, Bladder, Pancreas, Liver), and by Region - Forecast to 2026

Published: Upcoming | Forecast Period: 2021-2026 | Base Year: 2020
SKU: ICI-HC-1062 | Number of Pages: -- | Category: Biotechnology

The global cancer stem cells (CSC) market size is expected to witness a CAGR of X.X% during the forecast period. Rising prevalence of cancer, growing awareness for stem cell therapy benefits, and escalating preference for advanced cancer treatment are some of the major drivers of the CSC market. Factors such as increasing adaption of targeted therapies, growing R&D and government funding for building advanced infrastructure, and high success rate of patient health are also driving the global market growth. However, lack of skilled technical professionals and slow adoption in developing countries are expected to hinder the growth.

Major companies operating in the cancer stem cells market are Lineage Cell Therapeutics (U.S.); Lonza Group (Switzerland); Miltenyi Biotec (Germany); STEMCELL Technologies Inc. (Canada); Merck KGaA (Germany); AbbVie Inc. (U.S.); PromoCell GmbH (Germany); Mereo BioPharma (U.K.); Thermo Fisher Scientific (U.S.); and Berlin-Chemie AG (Germany). Rising investment in R&D, technological advancements, and strategic collaborations & acquisitions are some of the major strategies adopted by the leading players operating in the industry.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2017 to 2026. The cancer stem cells market report is categorized into the following segments and subsegments:

Cancer Stem Cells Market, By Mode of Action (Revenue, 2017-2026, USD Million)

  • Targeted Cancer Stem Cells (CSCs)
    • Target CSCs Market, By Anti-Cancer Stem Cell Therapeutics
      • Immuno-Evasion & Targeting Tumor Microenvironment
      • Surface Marker-Based
      • Nanoparticle-Based Therapies
      • Pathway Inhibitors
        • WNT Signalling Pathway
        • Hedgehog (HH) Signalling Pathway
        • Notch Signalling Pathway
        • Others
      • Others
    • Target CSCs Market, By Products
      • Cell Separation
      • Cell Culturing
      • Molecular Analysis
      • Cell Analysis
      • Others
  • Stem Cell-based Cancer Therapy
    • Allogeneic Stem Cell Transplant
    • Autologous Stem Cell Transplant

Cancer Stem Cells Market, By Cancer Type (Revenue, 2017-2026, USD Million)

  • Blood
  • Breast
  • Lungs
  • Colorectal
  • Brain
  • Bladder
  • Pancreas
  • Liver
  • Others

Cancer Stem Cells Market, By Region (Revenue, 2017-2026, USD Million)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Key questions addressed by the research report-

  1. What are the current market trends (2017 to 2020) and future market forecast from 2021 to 2026 for the market?
  2. What are the market dynamics and probable opportunities for market players during the forecast period?
  3. Initiatives undertaken my market players to address the COVID-19 impact to sustain in the competitive market.
  4. Which geographies have immense opportunities in different segments and sub-segments of the market?
  5. What are the recent strategies adopted by market players such as product launch, partnership, agreement, collaboration, merger & acquisition, and geographical expansion?



      Have any question? Check your free sample before purchase or connect with our expert.

      Additional information

      Licensing Types

      , , ,

      Enquire about Cancer Stem Cells Market Analysis by Mode of Action (Targeted Cancer Stem Cells, Stem Cell-based Cancer Therapy), by Cancer Type (Blood, Breast, Lungs, Colorectal, Brain, Bladder, Pancreas, Liver), and by Region - Forecast to 2026